May 02, 2012, 03.04 PM IST

Orchid Chemicals gets US FDA okay for Naratriptan Tablet

Orchid Chemicals and Pharmaceuticals has got US FDA okay for Naratriptan Tablet, reports CNBC-TV18.

Source: Moneycontrol.com
Share Share on Tumblr
Share  .  Email  .  Print  .  A+
Orchid Chemicals and Pharmaceuticals has got US FDA okay for Naratriptan Tablet, reports CNBC-TV18.


It touched an intraday high of Rs 183.40 and an intraday low of Rs 178.90. At 15:00 hrs the share was quoting at Rs 181.80, up Rs 2.15, or 1.20%.
 
It was trading with volumes of 124,178 shares. In the previous trading session, the share closed up 1.21% or Rs 2.15 at Rs 179.65.


The company's trailing 12-month (TTM) EPS was at Rs 22.64 per share. (Dec, 2011). The stock's price-to-earnings (P/E) ratio was 8.03. The latest book value of the company is Rs 160.99 per share. At current value, the price-to-book value of the company was 1.13. The dividend yield of the company was 1.65%.


 


Set email alert for

Flickr update may be unveiled at May 20 event
Advani, Swaraj can't wash their hands of  BJP's Karnataka defeat "Advani, Swaraj can't wash their hands of BJP's Karnataka defeat"

From DJ EU Officials Spain Aid Cap Of 100 Bn Euros 'should Be Enough'

The latest earning numbers FIRST on CNBC-TV18
News Videos

May 18 2013, 17:26

No asset class is risk-free: Axis Cap`s Nandan Chakraborty

- in MARKET OUTLOOK

May 17 2013, 12:39

F&O cues: Nifty to hover in 5800-6200, says Amit Trivedi

- in MARKET OUTLOOK